Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06785194 · ClinicalTrials.gov registry record
Revive Toric RWE Study
A clinical trial, sponsored by Bausch & Lomb Incorporated.
- Not yet
- Registry status
- 30
- Enrollment target
NCT06785194 is a clinical trial that has not yet begun recruiting, run by Bausch & Lomb Incorporated. The registered enrollment target is 30 participants.
The verdict
NCT06785194 has not yet begun recruiting, sponsored by Bausch & Lomb Incorporated.
- NOT YET RECRUITING
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a post-market observational clinical investigation. The objective of this observational study is to evaluate the visual performance and HCP satisfaction of REVIVE samfilcon B custom toric contact lenses.
Interventions
- DEVICE REVIVE samfilcon B custom toric contact lenses
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-05 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06785194
The ClinicalTrials.gov registry entry for NCT06785194 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which REVIVE samfilcon B custom toric contact lenses is the first listed.
NCT06785194 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06785194 about?
NCT06785194 is a clinical study titled "Revive Toric RWE Study". This is a post-market observational clinical investigation. The objective of this observational study is to evaluate the visual performance and HCP satisfaction of REVIVE samfilcon B custom toric contact lenses.
What is the current status of trial NCT06785194?
This trial is currently not yet recruiting. The enrollment target is 30 participants. The study started on 2026-05. Estimated completion is 2026-07.
What interventions are being tested in trial NCT06785194?
The interventions under investigation include: REVIVE samfilcon B custom toric contact lenses (DEVICE).
Who is sponsoring clinical trial NCT06785194?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.